Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; its reference list is not available.

Platelet-derived growth factor subunit B overexpression promotes lung cancer tumor growth and metastasis: The role of glucose metabolism

Open access
Feng, Kai, Cai, Xiaoping, Qiao, Gaofeng · 2025 · Cytojournal

Abstract

Objective: Lung cancer represents a formidable global health challenge due to its substantial prevalence and mortality rates. Metabolic reprogramming, especially the transition to aerobic glycolysis, plays a pivotal role in the progression of lung cancer by sustaining the energy demands for rapid tumor proliferation. The prominent involvement of platelet-derived growth factor subunit B (PDGFB) in promoting the growth and metastasis of lung cancer through specific signaling cascades is well established in. Nonetheless, further research is imperative to elucidate the intricate regulatory mechanisms of PDGFB in glucose metabolism and its implications for the advancement of lung cancer. Our study is dedicated to exploring the effect of PDGFB on lung cancer by modulating glucose metabolism. Material and Methods: First, we determined the expression patterns of PDGFB in various lung cancer cell lines (A549, H460, HCC827, and H1975) using quantitative real-time polymerase chain reaction and Western blot analyses. We measured the expression levels of PDGFB and Ki-67 in tumor tissues from lung cancer patients through immunohistochemistry. We then transfected lung cancer cells with a PDGFB overexpression (PDGFB OE) plasmid. The effects of PDGFB OE and galactose + PDGFB OE co-treatment on cell migration and invasion characteristics were assessed using wound healing and Transwell assays. The impact of PDGFB OE and galactose + PDGFB OE co-treatment on the proliferation capacity of lung cancer cells was evaluated through colony formation and 5-ethynyl-2’-deoxyuridine staining assays. We also measured the effects of PDGFB OE on mitochondrial function and glycolytic capacity in lung cancer cells using extracellular acidification rate assay (ECAR) measurement methods. Results: Elevated levels of PDGFB expression were markedly detected in various lung cancer cell lines, notably A549 and H460 (P < 0.001). This observation was validated by the analysis of tumor samples from patients with lung cancer who exhibited heightened PDGFB expression in tumor tissues (P < 0.001). Moreover, an association was found between increased levels of Ki67 expression and elevated PDGFB expression (P < 0.001). The upregulation of PDGFB was linked to heightened migratory (P < 0.001), invasive (P < 0.001), and proliferative (P < 0.001) capacities of the cells. Furthermore, an elevation in lactate levels and ECAR (P < 0.001) was noted in the PDGFB OE group, along with increased levels of glycolysis-related regulatory proteins. The inhibition of aerobic glycolysis with galactose effectively mitigated the PDGFB-induced enhancement of lung cancer cell proliferation and migration. Conclusion: By affecting glucose metabolism, PDGFB drives the growth and metastasis of lung cancer, underscoring its potential as a promising therapeutic target for the management of this complex disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.25259/cytojournal_190_2024

Cites

Statistics

Figures

Figure 1: PDGFB is upregulated in lung cancer cells, with its expression levels escalating with the progression of malignancy. (a) Western blot analysis of PDGFB in cell lines. (b) Histogram of relative PDGFB protein expression. (c) IHC analysis, objective: 200×, of PDGFB in tumor and adjacent normal tissue (n = 12) (d) Quantitative analysis of PDGFB expression levels in IHC staining. n = 6. ✶✶P < 0.01, ✶✶✶P < 0.001. Scale bar, 50 μm and 100 μm. PDGFB: Platelet-derived growth factor subunit B, GAPDH: Glyceraldehyde-3-phosphate dehydrogenase, IHC: Immunohistochemistry.
Figure 1: PDGFB is upregulated in lung cancer cells, with its expression levels escalating with the progression of malignancy. (a) Western blot analysis of PDGFB in cell lines. (b) Histogram of relative PDGFB protein expression. (c) IHC analysis, objective: 200×, of PDGFB in tumor and adjacent normal tissue (n = 12) (d) Quantitative analysis of PDGFB expression levels in IHC staining. n = 6. ✶✶P < 0.01, ✶✶✶P < 0.001. Scale bar, 50 μm and 100 μm. PDGFB: Platelet-derived growth factor subunit B, GAPDH: Glyceraldehyde-3-phosphate dehydrogenase, IHC: Immunohistochemistry.CC BY-NC-SA · PubMed Central
Figure 2: Overexpression of PDGFB in lung cancer cells led to enhanced migratory and invasive capabilities. (a and b) Western blot analysis of PDGFB in overexpression cell lines. (c) Histogram of relative PDGFB mRNA expression. (d) Wound-healing cell migration assay in A549 and H460. (e and f) Relative migration rate in A549 and H460. (g-i) Transwell chamber assays in A549 and H460. (j-l) Matrigel-coated Transwell chamber assays in A549 and H460. Scale bar, 100 μm. n = 6. ✶✶✶P < 0.001. Ctrl: Control, PDGFB OE: Overexpression of PDGFB, PDGFB: Platelet-derived growth factor subunit B.
Figure 2: Overexpression of PDGFB in lung cancer cells led to enhanced migratory and invasive capabilities. (a and b) Western blot analysis of PDGFB in overexpression cell lines. (c) Histogram of relative PDGFB mRNA expression. (d) Wound-healing cell migration assay in A549 and H460. (e and f) Relative migration rate in A549 and H460. (g-i) Transwell chamber assays in A549 and H460. (j-l) Matrigel-coated Transwell chamber assays in A549 and H460. Scale bar, 100 μm. n = 6. ✶✶✶P < 0.001. Ctrl: Control, PDGFB OE: Overexpression of PDGFB, PDGFB: Platelet-derived growth factor subunit B.CC BY-NC-SA · PubMed Central
Figure 3: Impact of PDGFB overexpression on the proliferation ability of lung cancer cells. (a and b) Analysis of proliferation ability of A549 and H460. (c-e) EdU incorporation assay, objective: 200×, was performed in A549 and H460. Scale bars, 100 μm. (f-h) Staining of Ki67 antibody in A549 and H460, objective: 200×. Scale bars, 50 μm. n = 6. ✶✶✶P < 0.001. EdU: 5-ethynyl-2’-deoxyuridine, PDGFB: Platelet-derived growth factor subunit B.
Figure 3: Impact of PDGFB overexpression on the proliferation ability of lung cancer cells. (a and b) Analysis of proliferation ability of A549 and H460. (c-e) EdU incorporation assay, objective: 200×, was performed in A549 and H460. Scale bars, 100 μm. (f-h) Staining of Ki67 antibody in A549 and H460, objective: 200×. Scale bars, 50 μm. n = 6. ✶✶✶P < 0.001. EdU: 5-ethynyl-2’-deoxyuridine, PDGFB: Platelet-derived growth factor subunit B.CC BY-NC-SA · PubMed Central
Figure 4: PDGFB modulates aerobic glycolysis of lung cancer cell. (a) Aerobic glycolysis of A549 cell. (b) Aerobic glycolysis of H460 cell. (c and d) Lactate levels analysis of A549 and H460. (e and f) Glucose uptake analysis of A549 and H460. (g and h) ATP levels analysis of A549 and H460. (i and j) PH value analysis of A549 and H460. (k-o) Western blot analysis of glycolysis-related regulatory protein levels in A549 and H460. n = 3. ✶✶P < 0.01, ✶✶✶P < 0.001. ECAR: Extracellular acidification rate, ATP: Adenosine triphosphate, HK2: Hexokinase 2, PKM2: Pyruvate kinase M2, GLUT1: Facilitative glucose transporter, LDHA: Lactate dehydrogenase, PDGFB: Platelet-derived growth factor subunit B.
Figure 4: PDGFB modulates aerobic glycolysis of lung cancer cell. (a) Aerobic glycolysis of A549 cell. (b) Aerobic glycolysis of H460 cell. (c and d) Lactate levels analysis of A549 and H460. (e and f) Glucose uptake analysis of A549 and H460. (g and h) ATP levels analysis of A549 and H460. (i and j) PH value analysis of A549 and H460. (k-o) Western blot analysis of glycolysis-related regulatory protein levels in A549 and H460. n = 3. ✶✶P < 0.01, ✶✶✶P < 0.001. ECAR: Extracellular acidification rate, ATP: Adenosine triphosphate, HK2: Hexokinase 2, PKM2: Pyruvate kinase M2, GLUT1: Facilitative glucose transporter, LDHA: Lactate dehydrogenase, PDGFB: Platelet-derived growth factor subunit B.CC BY-NC-SA · PubMed Central
Figure 5: PDGFB promoted lung cancer cell growth and metastasis through activating aerobic glycolysis. (a-c) Wound-healing cell migration assay with galactose in A549 and H460. (d-f) Transwell chamber assays with galactose in A549 and H460. (g-i) Matrigel invasion assays with galactose in A549 and H460. (j-l) Colony formation assays with galactose in A549 and H460. n = 4. ns: Not significant, ✶P < 0.01, ✶✶✶P < 0.001. PDGFB: Platelet-derived growth factor subunit B.
Figure 5: PDGFB promoted lung cancer cell growth and metastasis through activating aerobic glycolysis. (a-c) Wound-healing cell migration assay with galactose in A549 and H460. (d-f) Transwell chamber assays with galactose in A549 and H460. (g-i) Matrigel invasion assays with galactose in A549 and H460. (j-l) Colony formation assays with galactose in A549 and H460. n = 4. ns: Not significant, ✶P < 0.01, ✶✶✶P < 0.001. PDGFB: Platelet-derived growth factor subunit B.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 22 · Cited by 1

Metadata

Authors
Feng, K., Cai, X., & Qiao, G.
Affiliations
  • Binzhou People's Hospital (CN)
  • Shandong University (CN)
Corresponding author
Qiao, Gaofeng
Venue
Cytojournal
Published
2025-03-13
Volume
22
Pages
33
ISSN
  • 0974-5963 (ISSN-L)
  • 1742-6413
OpenAlex
W4408418935
Cited by
1
References
22
Citations by year
2026: 1
FWCI
0.45
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • CytoJournal (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
platelet-derived growth factor B, lung cancer, glucose metabolism, aerobic glycolysis, metabolic reprogramming, tumor growth, metastasis, cell migration and invasion, cell proliferation, galactose, mitochondrial function, lactate, PDGFRβ, Ki-67, tumor suppressor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Platelet-derived growth factor subunit B overexpression promotes lung cancer tumor growth and metastasis: The role of glucose metabolism. https://app.cochat.ai/papers/10.25259/cytojournal_190_2024
The paper
Feng, K., Cai, X., & Qiao, G. (2025). Platelet-derived growth factor subunit B overexpression promotes lung cancer tumor growth and metastasis: The role of glucose metabolism. Cytojournal. https://doi.org/10.25259/cytojournal_190_2024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.